CAM Innovative Drugs ETF(03525.HK) rose 1.50% to HK$10.150 as of 11:23 HKT on Sept 29, 2026, as Ascletis reported positive ASC50 psoriasis trial data.
iShares China Government Bond ETF(02829.HK) rose 0.09% to HK$64.180 as of 11:01 HKT on Sept 29, 2026, tracking the FTSE Chinese Government Bond Index.
iShares CSI 300 A-Share Index ETF(02846.HK) rose 0.17% to HK$34.420 as of 11:01 HKT on Sept 29, 2026, tracking the CSI 300 Index, with assets of HK$6.056bn.
ChinaAMC Ether ETF(03046.HK) rose 0.48% to HK$6.265 as of 10:46 HKT on Sept 29, 2026, tracking the CME CF Ether-Dollar Reference Rate with HK$371m assets.
CSOP Nikkei 225 (-2x) Inverse Product(07515.HK) rose 0.36% to HK$13.860 on Sept 29, 2026, as BOJ data showed Japan's August services producer prices rose 3.7%.
CSOP KOSPI 200 ETF(03121.HK) rose 0.45% to HK$6.705 as of 10:24 HKT on Sept 29, 2026, tracking the KOSPI 200 Index with HK$689m assets and a HK$6.673 NAV.
CSOP Hang Seng Biotech ETF(03174.HK) rose 2.89% to HK$3.914 as of 09:57 HKT on Sept 29, 2026, tracking the Hang Seng Biotech Index, with HK$972m assets.
On September 28, 2026, the HK shares ETFs market showed a defensive tilt. Global X K-Pop and Culture ETF (03158.HK) rose 3.01% to lead the gainers, followed by dividend and high-dividend-yield products, with six of the top ten gainers being dividend- and high-dividend-yield-related products. On the downside, growth and semiconductor themes pulled back sharply, with Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) down 8.84% at the top of the losers; 5G communications, optical communication, AI, semiconductor and little-giant segments led the declines, with all of the top ten falling at least 3.9%. Among southbound Stock Connect ETFs, dividend and broad-based products edged higher while AI and HK-Korea tech led the declines.
E Fund Liquor ETF(03189.HK) fell 1.28% to HK$1.076 as of 13:51 HKT on Sept 28, 2026, tracking the CSI Liquor Index with HK$83.36m assets and a HK$1.089 NAV.
As of 13:33 HKT on September 28, 2026, GlobalX China Biotech(02820.HK) fell 0.56% to HK$74.300 on HK$394,800 turnover, tracking Solactive China Biotech Index.
As of 13:32 HKT on September 28, 2026, iShares China(02801.HK) fell 0.42% to HK$23.480 on HK$3.19m turnover, tracking the MSCI China Index, board lot 200 units.
As of 13:06 HKT on September 28, 2026, Samsung S&P GSCI Crude Oil ER Futures ETF(03175.HK) rose 0.51% to HK$11.800 on HK$4.75m turnover, board lot 200 units.
As of 11:12 HKT on September 28, 2026, CSOP FTSE HK Equity ETF(03443.HK) rose 0.51% to HK$8.935 on HK$2.63m turnover, tracking the FTSE MPF Hong Kong Index.
As of 11:11 HKT on September 28, 2026, iShares India ETF(02836.HK) rose 0.59% to HK$34.260, tracking the S&P BSE SENSEX Index with assets of HK$4.514bn.
As of 10:46 HKT on September 28, 2026, CSOP Nikkei 225 Daily (-2x) Inverse Product(07515.HK) rose 0.74% intraday to HK$13.610, tracking the Nikkei 225 Index.
As of 10:46 HKT on September 28, 2026, Tracker Fund of Hong Kong(02800.HK) rose 0.80% to HK$25.320 on HK$2.77bn turnover, tracking the Hang Seng Index.
